Trial Profile
131-I-TM-601 dosimetry after a single and multiple doses of intracavitary administered 131-I-TM-601 in patients with high-grade glioma
Status:
Not yet recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 23 Apr 2007
Price :
$35
*
At a glance
- Drugs TM 601 I-131 (Primary)
- Indications Glioma
- Focus Pharmacokinetics
- Sponsors TransMolecular
- 23 Apr 2007 New trial record.